Ultragenyx Pharmaceutical (RARE) Gross Margin Growth (3y) (2021 - 2026)
Ultragenyx Pharmaceutical (RARE) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 7,249.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -191.00 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Ultragenyx Pharmaceutical | 2.45 Bn | 2.05 Bn | 106.00 Mn | -986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -986.00 |
| Dec 31, 2025 | -901.00 |
| Sep 30, 2025 | -799.00 |
| Jun 30, 2025 | -456.00 |
| Mar 31, 2025 | -1,323.00 |
| Dec 31, 2024 | -622.00 |
| Sep 30, 2024 | -996.00 |
| Jun 30, 2024 | -1,087.00 |
| Mar 31, 2024 | -1,089.00 |
| Dec 31, 2023 | -333.00 |
| Sep 30, 2023 | -832.00 |
| Jun 30, 2023 | -623.00 |
| Mar 31, 2023 | -255.00 |
| Dec 31, 2022 | 920.00 |
| Sep 30, 2022 | 88.00 |
| Jun 30, 2022 | -608.00 |
| Mar 31, 2022 | -514.00 |
| Dec 31, 2021 | -109.00 |
| Sep 30, 2021 | -279.00 |
| Jun 30, 2021 | -250.00 |